Nuveen Asset Management, LLC Staar Surgical CO Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 163,427 shares of STAA stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
163,427
Previous 163,412 0.01%
Holding current value
$3.91 Million
Previous $7.78 Million 21.97%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.97 - $47.42 $449 - $711
15 Added 0.01%
163,427 $6.07 Million
Q2 2024

Aug 09, 2024
SELL
$38.07 - $52.25 $539,109 - $739,912
-14,161 Reduced 7.97%
163,412 $7.78 Million
Q1 2024

May 13, 2024
SELL
$27.67 - $39.61 $668,590 - $957,096
-24,163 Reduced 11.98%
177,573 $6.8 Million
Q4 2023

Feb 14, 2024
BUY
$30.6 - $43.78 $22,429 - $32,090
733 Added 0.36%
201,736 $6.3 Million
Q3 2023

Nov 14, 2023
BUY
$39.39 - $58.12 $63,575 - $93,805
1,614 Added 0.81%
201,003 $8.08 Million
Q2 2023

Aug 14, 2023
SELL
$50.45 - $72.82 $9.47 Million - $13.7 Million
-187,731 Reduced 48.49%
199,389 $10.5 Million
Q1 2023

May 15, 2023
BUY
$51.25 - $79.34 $9.41 Million - $14.6 Million
183,701 Added 90.31%
387,120 $24.8 Million
Q4 2022

Feb 14, 2023
SELL
$46.82 - $76.2 $943,235 - $1.54 Million
-20,146 Reduced 9.01%
203,419 $9.87 Million
Q3 2022

Nov 14, 2022
SELL
$70.55 - $111.58 $2.22 Million - $3.51 Million
-31,439 Reduced 12.33%
223,565 $15.8 Million
Q2 2022

Aug 15, 2022
BUY
$50.24 - $80.48 $432,767 - $693,254
8,614 Added 3.5%
255,004 $18.1 Million
Q1 2022

May 16, 2022
SELL
$57.98 - $93.5 $850,740 - $1.37 Million
-14,673 Reduced 5.62%
246,390 $18.3 Million
Q4 2021

Feb 14, 2022
SELL
$88.02 - $127.79 $1.91 Million - $2.77 Million
-21,651 Reduced 7.66%
261,063 $23.8 Million
Q3 2021

Nov 12, 2021
SELL
$122.75 - $162.68 $1.77 Million - $2.35 Million
-14,442 Reduced 4.86%
282,714 $36.3 Million
Q2 2021

Aug 16, 2021
SELL
$105.76 - $154.96 $939,677 - $1.38 Million
-8,885 Reduced 2.9%
297,156 $45.3 Million
Q1 2021

May 17, 2021
SELL
$78.5 - $126.48 $2.89 Million - $4.66 Million
-36,805 Reduced 10.74%
306,041 $32.3 Million
Q4 2020

May 17, 2021
BUY
$55.93 - $82.78 $1.49 Million - $2.2 Million
26,632 Added 8.42%
342,846 $27.2 Million
Q4 2020

Feb 16, 2021
SELL
$55.93 - $82.78 $2.83 Million - $4.18 Million
-50,530 Reduced 13.78%
316,214 $25.1 Million
Q3 2020

Nov 16, 2020
BUY
$45.65 - $61.81 $175,204 - $237,226
3,838 Added 1.06%
366,744 $20.7 Million
Q2 2020

Aug 14, 2020
SELL
$29.15 - $61.54 $3.19 Million - $6.74 Million
-109,491 Reduced 23.18%
362,906 $22.3 Million
Q1 2020

May 14, 2020
SELL
$25.01 - $42.4 $1.4 Million - $2.38 Million
-56,158 Reduced 10.62%
472,397 $15.2 Million
Q4 2019

Feb 14, 2020
SELL
$24.55 - $38.13 $706,008 - $1.1 Million
-28,758 Reduced 5.16%
528,555 $18.6 Million
Q3 2019

Nov 14, 2019
SELL
$25.78 - $34.8 $4.66 Million - $6.29 Million
-180,856 Reduced 24.5%
557,313 $14.4 Million
Q2 2019

Aug 15, 2019
BUY
$23.08 - $37.01 $16.3 Million - $26.1 Million
705,217 Added 2140.13%
738,169 $21.7 Million
Q1 2019

May 14, 2019
BUY
$27.81 - $40.78 $103,786 - $152,190
3,732 Added 12.77%
32,952 $1.13 Million
Q4 2018

Feb 14, 2019
BUY
$28.91 - $50.0 $141,022 - $243,900
4,878 Added 20.04%
29,220 $932,000
Q3 2018

Nov 13, 2018
BUY
$30.85 - $50.65 $750,950 - $1.23 Million
24,342 New
24,342 $1.17 Million

Others Institutions Holding STAA

# of Institutions
255
Shares Held
47.8M
Call Options Held
427K
Put Options Held
206K
View Full List

About STAAR SURGICAL CO

STAA Quotes by TradingView
  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email